Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer

Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer

Dance Biopharm Holdings Inc. , a private biotechnology company focused on developing transformational healthcare solutions to treat diabetes and other serious chronic diseases, is pleased to announce that Anne Whitaker has been appointed as a Director and Chief Executive Officer. Ms. Whitaker will take up her new position on October 1st, 2018.

from Biotech News